Onderzoeker

Ludo Vanopdenbosch

Disciplines:Orthopedie, Humane bewegings- en sportwetenschappen, Revalidatiewetenschappen

Publicaties

1 - 10 van 47

The involvement of palliative care with neurology - a comparison of UK, Switzerland and Italy(2023)
Auteurs: Ludo Vanopdenbosch
Pagina's: 256 - 262
Treatment-naive patients with early-stage relapsingremitting multiple sclerosis showed low disease activity after 2-year ocrelizumab therapy, with no new safety signals; the Phase IIIb ENSEMBLE study(2022)
Auteurs: Ludo Vanopdenbosch
Pagina's: 325 - 326
Safety of shorter ocrelizumab infusion confirmed over multiple administrations: results of the ENSEMBLE PLUS substudy(2022)
Auteurs: Ludo Vanopdenbosch
Pagina's: 647 - 649
Neuropalliative care in times of war(2022)
Auteurs: Ludo Vanopdenbosch
Pagina's: 3130 - 3131
Two related cases of super-refractory status epilepticus due to 4-aminopyridine intoxication and an overview of the literature(2021)
Auteurs: Ludo Vanopdenbosch
Pagina's: 527 - 530
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis.(2020)
Auteurs: Ludo Vanopdenbosch
Pagina's: 102492
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.(2020)
Auteurs: Ludo Vanopdenbosch
Pagina's: 912 - 923
Cerebellar progressive multifocal leukoencephalopathy in a patient with a history of Crohn's disease and acute myeloid leukemia(2020)
Auteurs: Ludo Vanopdenbosch
Pagina's: 759 - 760
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial(2019)
Auteurs: Melissa Cambron, Jop Mostert, Marie D'Hooghe, Guy Nagels, Barbara Willkens, Jan Debruyne, Luc Algoed, Winn Verhagen, Raymond Hupperts, Dorothea Heersema, et al.
Pagina's: 1728 - 1735
There is an urgent need for palliative care specialists in MS - No(2019)
Auteurs: Ludo Vanopdenbosch
Pagina's: 1712 - 1713

Onderzoeker

Ludo Vanopdenbosch

Affiliaties

Publicaties